Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Allergan, Inc. patentsThe following is a sampling of recent Allergan, Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
August 2012 - Allergan, Inc. patents
20120219611 - Hypotensive lipid-containing biodegradable intraocular implants and related methods
20120219627 - Compositions and improved soft tissue replacement methods
20120221037 - Bariatric device and method for weight loss
20120221105 - Prosthetic device and method of manufacturing the same
20120221104 - Prosthetic device and method of manufacturing the same
20120210547 - Immunoneutral silk-fiber-based medical devices
20120213852 - Compositions and improved soft tissue replacement methods
20120213853 - Compositions and improved soft tissue replacement methods
20120214229 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120214837 - Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
20120214838 - Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
20120214842 - Methods for treating diseases of the retina
20120215062 - Remotely adjustable gastric banding device
20120215061 - Hydraulic gastric band with reversible self-opening mechanism
20120207704 - Inhibiting aberrant blood vessel formation using growth factor retargeted endopeptidases
20120207734 - Methods of inhibiting aberrant blood vessel formation using opioid retargeted endpeptidases
20120207733 - Treating a disease of hyperproliferation using retargeted endopeptidases
20120207743 - Inhibiting aberrant blood vessel formation using retargeted endopeptidases
20120207742 - Treatments using psma ligand endopeptidases
20120207787 - Animal protein-free pharmaceutical compositions
20120207837 - Bioerodible matrix for tissue involvement
20120208272 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120208271 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120208840 - Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors
20120208858 - Pharmaceutical cream compositions of oxymetazoline and methods of use
20120208890 - Stable hydrogel compositions including additives
20120209381 - Bioerodible matrix for tissue involvement
20120202886 - Method of enhancing hair growth
20120203061 - Bariatric device and method for weight loss
20120195878 - Protocol for the administration of botulinum toxins
20120196911 - Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
20120196914 - Ketorolac tromethamine compositions for treating or preventing ocular pain
20120196913 - Ketorolac tromethamine compositions for treating or preventing ocular pain
July 2012 - Allergan, Inc. patents
20120189590 - Compositions and improved soft tissue replacement methods
20120189591 - Compositions and improved soft tissue replacement methods
20120189589 - Compositions and improved soft tissue replacement methods
20120189699 - Polysaccharide gel formulation having multi-stage bioactive agent delivery
20120189708 - Compositions and improved soft tissue replacement methods
20120190694 - Selective sphingosine-1-phosphate receptor antagonists
20120190719 - Methods of treating motor disorders with alpha-2b andrenergic receptor agonists
20120190722 - Ketorolac tromethamine compositions for treating or preventing ocular pain
20120191125 - Intragastric implants with multiple fluid chambers
20120185041 - Silk medical device for use in breast augmentation and breast reconstruction
20120177585 - Compositions and methods for treating purpura
20120178140 - Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems
20120178798 - Substituted cyclopentanes having prostaglandin activity
20120179253 - Prosthetic device and method of manufacturing the same
20120179252 - Prosthetic device and method of manufacturing the same
20120169732 - Method for analysis of facial appearance to assist medical procedure
20120171265 - Silk fibroin hydrogels and uses thereof
20120172317 - Silk fibroin hydrogels and uses thereof
20120172328 - Hyaluronic acid-based gels including lidocaine
20120172985 - Silk fibroin hydrogels and uses thereof
June 2012 - Allergan, Inc. patents
20120164098 - Crossed-linked hyaluronic acid and collagen and uses thereof
20120164116 - Compositions and methods for tissue filling and regeneration
20120164728 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120165380 - Methods of treating alpha adrenergic mediated conditions
20120165382 - Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
20120165935 - Compositions and methods for tissue filling and regeneration
20120165934 - Collapsible, form-stable, fillable breast prosthesis
20120156720 - Compositions and methods of producing enterokinase in yeast
20120156756 - Process and system for obtaining botulinum neurotoxin
20120156769 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120156775 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120156776 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120156774 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120157413 - Phosphorous derivatives as chemokine receptor modulators
20120157444 - Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
20120157487 - Sulfur derivatives as chemokine receptor modulators
20120157497 - Compounds having analgesic and/or immunostimulant activity
20120157499 - Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
20120148563 - Method for treating premature ejaculation with a botulinum neurotoxin
20120149089 - Animal product free system and process for purifying a botulinum toxin
20120149105 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120149106 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120149104 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120149103 - Cells useful for immuno-based botulinum toxin serotype a activity assays
20120149643 - Safe desmopressin administration
20120149747 - Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
20120149746 - Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
20120149748 - Pharmaceutical cream compositions and methods of use
20120150204 - Implantable silk prosthetic device and uses thereof
20120139157 - Flush patch for elastomeric implant shell
20120141619 - Non-protein stabilized clostridial toxin pharmaceutical compositions
20120142628 - Methods for treating crepitus
20120142639 - Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
20120142640 - Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
20120142642 - Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
20120142652 - Compositions and methods for localized therapy of the eye
20120142662 - Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
20120142661 - Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
20120142664 - Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
20120142663 - Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
20120142675 - Methods for treating diseases of the retina
20120142684 - Compounds and methods for skin repair
20120142726 - Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
20120142736 - Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
20120142739 - Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
20120142740 - Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
20120142745 - Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
20120142746 - Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
20120142783 - Enhanced bimatoprost ophthalmic solution
20120142782 - Enhanced cimatoprost ophthalmic solution
20120142798 - Process for texturing materials
20120143328 - Variable cohesive gel form-stable breast implant
May 2012 - Allergan, Inc. patents
20120135495 - Neurotoxins with enhanced target specificity
20120135939 - Cyclosporin analogs
20120136041 - Treating ocular diseases using peroxisome proliferator-activated receptor delta antagonists
20120136011 - Compounds and methods for skin repair
20120136035 - 4-(1-(3-(hydroxymethyl)-2-methylphenyl)ethyl)-1h-imidazole-2(3h)-thione
20120136036 - Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
20120129814 - Novel phosphonic acids as s1p receptor modulators
20120129829 - Novel indole modulators of s1p receptors
20120129906 - Modulators of s1p receptors
20120122802 - Animal protein-free pharmaceutical compositions
20120122821 - Steroid-containing sustained release intraocular implants and related methods
20120122945 - Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
20120122989 - Method of enhancing hair growth
20120123095 - Process and system for obtaining botulinum neurotoxin
20120123196 - Gastric band devices and drive systems
20120123537 - Tissue expander with self-healing anterior side
20120114703 - Botulinum toxin administration to treat various conditions
20120115205 - Botulinum neurotoxin serotype b activatable botulinum neurotoxin serotype bs
20120115792 - Method for the treatment of infraorbital dark circles using botulinum toxins
20120108792 - Process and system for obtaining botulinum neurotoxin
20120108921 - Gastric banding system adjustment based on a satiety agent concentration level
20120109080 - Puncture resistant composite materials
April 2012 - Allergan, Inc. patents
20120101478 - Dual cartridge mixer syringe
20120101574 - Implantable materials
20120093827 - Treatment of autoimmune disorders with a neurotoxin
20120094359 - Novel system and method of anaerobic fermentation
20120095288 - Self-adjusting gastric band
20120095385 - Intragastric implants with duodenal anchors
20120095384 - Stomach-spanning gastric implants
20120095483 - Anchored non-piercing duodenal sleeve and delivery systems
20120095484 - Articulated gastric implant clip
20120095497 - Non-inflatable gastric implants and systems
20120095496 - Reactive intragastric implant devices
20120095495 - Space-filling intragastric implants with fluid flow
20120095494 - Intragastric implants with collapsible frames
20120095493 - Elevating stomach stimulation device
20120095492 - Variable size intragastric implant devices
20120095499 - Upper stomach gastric implants
20120088714 - System for storage and subsequent handling of botulinum toxin
20120088734 - Cyclosporin analogs
20120088800 - 2-(substituted) (arylmethyl, aryloxy and arylthio))-n-(substituted pyridin-2-yl)-2-(substituted aryl) compounds as subtype-selective modulators of sphingosine-1-phosphate-3 (s1p3) receptors
20120088962 - Self-adjusting gastric band
20120089172 - Re-shaping intragastric implants
20120089170 - Intragastric balloon geometries
20120083508 - Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain
20120083650 - Systems and methods for adjusting gastric band pressure
March 2012 - Allergan, Inc. patents
20120077010 - Porous materials, methods of making and uses
20120077012 - Porous materials, methods of making and uses
20120077858 - Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
20120077857 - Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
20120077891 - Porogen compositions, methods of making and uses
20120078831 - Breast implant surgical decision support system and method
20120071437 - Tunable crosslinked polysaccharide compositions
20120071448 - S1p3 receptor inhibitors for treating conditions of the eye
20120065141 - Stabilized biodegradable neurotoxin implants
20120065178 - Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
20120059060 - Valproic acid drug delivery systems and intraocular therapeutic uses thereof
20120059216 - Remotely adjustable gastric banding system
20120059462 - Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
20120052548 - Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
20120053127 - Targeted delivery of botulinum toxin to the sphenopalatine ganglion
20120053126 - Injection paradigm for administration of botulinum toxins
20120053612 - Apparatus and method for intragastric balloon with in situ adjustment means
February 2012 - Allergan, Inc. patents
20120045420 - Compositions and improved soft tissue replacement methods
20120045431 - Method of stabilizing and sterilizing peptides or proteins
20120046332 - Compositions and methods for treating corneal haze
20120046520 - Pare piezo power with energy recovery
20120046674 - Power regulated implant
20120041258 - Implantable access port system
20120041555 - Silicone implant with imprinted texture
20120034462 - Hair-like shaped hydrogels for soft tissue augmentation
20120035146 - Implants and methods for treating inflammation-mediated conditions of the eye
20120035235 - Methods of treating alpha adrenergic mediated conditions
January 2012 - Allergan, Inc. patents
20120021969 - Prosthetic implant shell
20120021991 - Use of a botulinum neurotoxin to alleviate various disorders
20120022034 - Methods for reducing or neovascularization or edema
20120022646 - Prosthetic device and method of using in breast augmentation and/or breast reconstruction
20120015978 - Therapeutic agents for ocular hypertension
20120010706 - Non-rotating implant assembly and backing plate therefor
20120003230 - Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
20120003275 - Compositions and methods for the treatment of ophthalmic disease
20120004723 - Prosthetic device and method of using in breast augmentation and/or breast reconstruction
20120004722 - Degradation resistant implantable materials and methods
August 2011 - Allergan, Inc. patents
20110200639 - Botulinum toxin treatments of depression
20110201684 - Ep2 agonist from non-prostanoid structures designed as pge2 antagonists
20110201875 - Remotely adjustable gastric banding system
20110201874 - Remotely adjustable gastric banding system
20110196195 - Implantable subcutaneous access port
20110196313 - Extendable plunger rod for medical syringe
20110196394 - Implantable injection port
20110196488 - Degradation resistant implantable materials and methods
20110196489 - Biocompatible structures and compositions
20110189162 - Modified clostridial toxins comprising an integrated protease cleavage site-binding domain
20110189292 - Dermal fillers comprising silk fibroin hydrogels and uses thereof
20110189773 - Silk fibroin fiber bundles for matrices in tissue engineering
20110190286 - Therapeutically active cyclopentanes
20110190301 - Substituted cyclopentanes or cyclopentanones as therapeutic agents
July 2011 - Allergan, Inc. patents
20110182966 - Intracameral sustained release therapeutic agent implants
20110184055 - Therapeutic agents for treatment of ocular hypertension
20110184229 - Laparoscopic gastric band with active agents
20110184227 - Prosthetic device and method of manufacturing the same
20110184531 - Open celled foams, implants including them and processes for making same
20110177053 - Non-cytotoxic protein conjugates
20110178084 - Therapeutic compounds
20110178143 - Therapeutic compounds
20110178144 - Therapeutic compounds
20110178145 - Alpha-2 adrenergic agonist having long duration ofintraocular pressure-lowering effect
20110178147 - Compositions and methods for controlling pupil dilation
20110167602 - Immunoneutral silk-fiber-based medical devices
20110171453 - Immunoneutral silk-fiber-based medical devices
20110172299 - Therapeutic substituted cyclopentanes
20110172435 - Treatment of inflammatory bowel disease
20110172502 - Diary/planner for breast surgery preparation and method
20110166531 - Syringe
June 2011 - Allergan, Inc. patents
20110160271 - Ketorolac tromethamine compositions for treating or preventing ocular pain
20110160617 - Clinical assessment scales and methods
20110150846 - Compositions and methods for tissue filling and regeneration
20110152198 - Pharmaceutical compositions containing botulinum toxin
20110152241 - Novel compounds as receptor modulators with therapeutic utility
20110152376 - 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof
20110152608 - Flow control method and device
20110152797 - Prostaglandins and analogues as agents for lowering intraocular pressure
20110144670 - Flow control method and device
20110136884 - Selective subtype alpha 2 adrenergic agents and methods for use thereof
20110137112 - Gastric band with electric stimulation
20110137260 - Slotted syringe
20110137286 - Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form
20110129531 - Dermal fillers comprising silk fibroin hydrogels and uses thereof
20110130439 - Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
May 2011 - Allergan, Inc. patents
20110124121 - Methods for predicting weight loss success
20110124737 - Enhanced bimatoprost ophthalmic solution
20110124736 - Compositions and methods for stimulating hair growth
20110117182 - Combination of dapsone with other anti-acne agents
20110117267 - Soft prosthesis shell texturing method
20110111479 - Botulinum neurotoxin serotype b activatable botulinum neurotoxin serotype bs
20110111483 - Optimizing expression of active botulinum toxin type e
20110112198 - Compositions for enhancing hair growth
20110105567 - Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity
20110105581 - Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
April 2011 - Allergan, Inc. patents
20110091437 - Fusion proteins
20110091520 - Sustained release intraocular implants and methods for treating ocular neuropathies
20110092443 - Cyclosporine compositions for enhancing nail growth
20110092916 - Injection device
20110093069 - Implants and methdos for manufacturing same
March 2011 - Allergan, Inc. patents
20110076318 - Retinoid-containing sustained release intraocular implants and related matters
20110077229 - Steroid containing drug delivery systems
20110077274 - Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
20110077737 - Tunably crosslinked polysaccharide compositions
20110070186 - Methods of treating cancer using growth factor retargeted endopeptidases
20110070212 - Methods of treating cancer using glucagon-like hormone retargeted endopeptidases
20110070211 - Methods of treating cancer using galanin retargeted endopepidases
20110070215 - Methods of treating cancer using neurotrophin retargeted endopeptidases
20110070621 - Multivalent clostridial toxins
20110064713 - Methods of treating cancer using opioid retargeted endopepidases
20110065748 - Compositions and methods for treating disorders of gastrointestinal motility
20110065747 - Compositions and methods for treating seizure disorders
20110052695 - Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
20110053905 - Compounds as tyrosine kinase modulators
20110053973 - Compounds as tyrosine kinase modulators
20110054248 - Gastric band with electric stimulation
20110054407 - System including access port and applicator tool
February 2011 - Allergan, Inc. patents
20110046177 - Therapeutic quinoline and naphthalene derivatives
20110046198 - Ketorolac tromethamine compositions for treating or preventing ocular pain
20110046356 - Post-translational modifications and clostridial neurotoxins
20110046729 - Reinforced prosthetic implant with flexible shell
20110038871 - Ccr2 inhibitors for treating conditions of the eye
20110039790 - Enhanced ocular neuroprotection and neurostimulation
20110039864 - Therapeutic compounds
20110039866 - Selective sphingosine-1-phosphate receptor antagonists
20110039900 - Isothiozoles for treating conditions of the eye
20110040141 - Closure system for tubular organs
20110034448 - Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
20110034517 - Selective subtype alpha 2 adrenergic agents and methods for use thereof
20110034525 - Nonsedating alpha-2 agonists
20110028523 - Selective alpha 2b/2c agonists
20110028559 - Substituted fluoroethyl ureas as alpha 2 adrenergic agents
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Allergan, Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Allergan, Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support - Terms & Conditions
|
REGISTER now for FREE 
